Seroquel, initially approved for schizophrenia, faces scrutiny over its 'off-label' uses for conditions like insomnia and PTSD. Concerns over potential risks, such as diabetes and heart issues, alongside legal and regulatory challenges, highlight the need for careful prescription practices and patient awareness.